Clinimetric testing of the comprehensive cervical dystonia rating scale
- 12 March 2016
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 31 (4) , 563-569
Abstract
Introduction: The aim of this study was to test the clinimetric properties of the Comprehensive Cervical Dystonia Rating Scale. This is a modular scale with modifications of the Toronto Western Spasmodic Torticollis Rating Scale (composed of three subscales assessing motor severity, disability, and pain) now referred to as the revised Toronto Western Spasmodic Torticollis Scale‐2; a newly developed psychiatric screening instrument; and the Cervical Dystonia Impact Profile‐58 as a quality of life measure.Methods: Ten dystonia experts rated subjects with cervical dystonia using the comprehensive scale. Clinimetric techniques assessed each module of the scale for reliability, item correlation, and factor structure.Results: There were 208 cervical dystonia patients (73% women; age, 59 ± 10 years; duration, 15 ± 12 years). Internal consistency of the motor severity subscale was acceptable (Cronbach's alpha = 0.57). Item to total correlations showed that elimination of items with low correlations (<0.20) increased alpha to 0.71. Internal consistency estimates for the subscales for disability and pain were 0.88 and 0.95, respectively. The psychiatric screening scale had a Cronbach's alpha of 0.84 and satisfactory item to total correlations. When the subscales of the Toronto Western Spasmodic Torticollis Scale‐2 were combined with the psychiatric screening scale, Cronbach's alpha was 0.88, and construct validity assessment demonstrated four rational factors: motor; disability; pain; and psychiatric disorders. The Cervical Dystonia Impact Profile‐58 had an alpha of 0.98 and its construction was validated through a confirmatory factor analysis.Conclusions: The modules of the Comprehensive Cervical Dystonia Rating Scale are internally consistent with a logical factor structure. © 2016 International Parkinson and Movement Disorder SocietyKeywords
Funding Information
- National Institutes of Health (NS 065701)
- National Institute of Neurological Disorders and Stroke
- Office of Rare Diseases Research at the National Center for Advancing Translational Sciences, NIH
- Dystonia Medical Research Foundation
- Allergan Inc
- Dystonia Coalition (NS065701)
- NIH (R01NS074343, U54NS065701)
This publication has 40 references indexed in Scilit:
- Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapyJournal of Neural Transmission, 2012
- Nonmotor manifestations of dystonia: A systematic reviewMovement Disorders, 2011
- The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?Health and Quality of Life Outcomes, 2008
- Experimental Therapeutics for DystoniaNeurotherapeutics, 2008
- Determinants and status of quality of life after long‐term botulinum toxin therapy for cervical dystoniaEuropean Journal of Neurology, 2007
- Classical Test TheoryMedical Care, 2006
- Treatment of cervical dystonia: A comparison of measures for outcome assessmentMovement Disorders, 1998
- On the Validity of the Beck Depression InventoryPsychopathology, 1998
- DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLISThe Lancet, 1986
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983